nodes	percent_of_prediction	percent_of_DWPC	metapath
Ceftazidime—SLC22A6—Cyclosporine—focal segmental glomerulosclerosis	0.722	1	CbGbCtD
Ceftazidime—SLC22A6—nephron tubule—focal segmental glomerulosclerosis	0.014	0.164	CbGeAlD
Ceftazidime—Nephropathy—Cyclosporine—focal segmental glomerulosclerosis	0.0138	0.0716	CcSEcCtD
Ceftazidime—SLC22A6—cortex of kidney—focal segmental glomerulosclerosis	0.012	0.141	CbGeAlD
Ceftazidime—SLC15A1—nephron tubule—focal segmental glomerulosclerosis	0.0117	0.137	CbGeAlD
Ceftazidime—Nephropathy toxic—Cyclosporine—focal segmental glomerulosclerosis	0.0114	0.0594	CcSEcCtD
Ceftazidime—Gastrointestinal symptom NOS—Cyclosporine—focal segmental glomerulosclerosis	0.0111	0.058	CcSEcCtD
Ceftazidime—SLC15A1—kidney—focal segmental glomerulosclerosis	0.0102	0.12	CbGeAlD
Ceftazidime—Encephalopathy—Cyclosporine—focal segmental glomerulosclerosis	0.0102	0.0531	CcSEcCtD
Ceftazidime—Cholestasis—Cyclosporine—focal segmental glomerulosclerosis	0.00863	0.0449	CcSEcCtD
Ceftazidime—SLC15A2—nephron tubule—focal segmental glomerulosclerosis	0.00729	0.0856	CbGeAlD
Ceftazidime—Hyperbilirubinaemia—Cyclosporine—focal segmental glomerulosclerosis	0.0072	0.0375	CcSEcCtD
Ceftazidime—SLC15A2—kidney—focal segmental glomerulosclerosis	0.00641	0.0752	CbGeAlD
Ceftazidime—SLC22A5—nephron tubule—focal segmental glomerulosclerosis	0.00634	0.0744	CbGeAlD
Ceftazidime—Candida infection—Cyclosporine—focal segmental glomerulosclerosis	0.00625	0.0326	CcSEcCtD
Ceftazidime—SLC15A2—cortex of kidney—focal segmental glomerulosclerosis	0.00624	0.0732	CbGeAlD
Ceftazidime—Coma—Cyclosporine—focal segmental glomerulosclerosis	0.00599	0.0312	CcSEcCtD
Ceftazidime—SLC22A5—kidney—focal segmental glomerulosclerosis	0.00557	0.0654	CbGeAlD
Ceftazidime—Hepatic function abnormal—Cyclosporine—focal segmental glomerulosclerosis	0.00544	0.0283	CcSEcCtD
Ceftazidime—SLC22A5—cortex of kidney—focal segmental glomerulosclerosis	0.00543	0.0637	CbGeAlD
Ceftazidime—Hot flush—Cyclosporine—focal segmental glomerulosclerosis	0.00508	0.0265	CcSEcCtD
Ceftazidime—Menopausal symptoms—Cyclosporine—focal segmental glomerulosclerosis	0.00504	0.0262	CcSEcCtD
Ceftazidime—Renal impairment—Cyclosporine—focal segmental glomerulosclerosis	0.005	0.026	CcSEcCtD
Ceftazidime—Lethargy—Cyclosporine—focal segmental glomerulosclerosis	0.00485	0.0253	CcSEcCtD
Ceftazidime—Bronchospasm—Cyclosporine—focal segmental glomerulosclerosis	0.00404	0.021	CcSEcCtD
Ceftazidime—Infestation NOS—Cyclosporine—focal segmental glomerulosclerosis	0.00366	0.0191	CcSEcCtD
Ceftazidime—Infestation—Cyclosporine—focal segmental glomerulosclerosis	0.00366	0.0191	CcSEcCtD
Ceftazidime—Renal failure—Cyclosporine—focal segmental glomerulosclerosis	0.0036	0.0188	CcSEcCtD
Ceftazidime—Jaundice—Cyclosporine—focal segmental glomerulosclerosis	0.00357	0.0186	CcSEcCtD
Ceftazidime—Hepatobiliary disease—Cyclosporine—focal segmental glomerulosclerosis	0.00347	0.018	CcSEcCtD
Ceftazidime—Haemoglobin—Cyclosporine—focal segmental glomerulosclerosis	0.00331	0.0172	CcSEcCtD
Ceftazidime—Haemorrhage—Cyclosporine—focal segmental glomerulosclerosis	0.00329	0.0171	CcSEcCtD
Ceftazidime—Flushing—Cyclosporine—focal segmental glomerulosclerosis	0.00305	0.0159	CcSEcCtD
Ceftazidime—Angiopathy—Cyclosporine—focal segmental glomerulosclerosis	0.00298	0.0155	CcSEcCtD
Ceftazidime—Dysgeusia—Cyclosporine—focal segmental glomerulosclerosis	0.0028	0.0146	CcSEcCtD
Ceftazidime—Vision blurred—Cyclosporine—focal segmental glomerulosclerosis	0.0027	0.014	CcSEcCtD
Ceftazidime—Tremor—Cyclosporine—focal segmental glomerulosclerosis	0.00268	0.014	CcSEcCtD
Ceftazidime—Agitation—Cyclosporine—focal segmental glomerulosclerosis	0.00263	0.0137	CcSEcCtD
Ceftazidime—Angioedema—Cyclosporine—focal segmental glomerulosclerosis	0.00262	0.0136	CcSEcCtD
Ceftazidime—Leukopenia—Cyclosporine—focal segmental glomerulosclerosis	0.00256	0.0133	CcSEcCtD
Ceftazidime—Convulsion—Cyclosporine—focal segmental glomerulosclerosis	0.00248	0.0129	CcSEcCtD
Ceftazidime—Unspecified disorder of skin and subcutaneous tissue—Cyclosporine—focal segmental glomerulosclerosis	0.00242	0.0126	CcSEcCtD
Ceftazidime—Anaphylactic shock—Cyclosporine—focal segmental glomerulosclerosis	0.00234	0.0122	CcSEcCtD
Ceftazidime—Nervous system disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00229	0.0119	CcSEcCtD
Ceftazidime—Thrombocytopenia—Cyclosporine—focal segmental glomerulosclerosis	0.00229	0.0119	CcSEcCtD
Ceftazidime—Skin disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00227	0.0118	CcSEcCtD
Ceftazidime—Paraesthesia—Cyclosporine—focal segmental glomerulosclerosis	0.0021	0.0109	CcSEcCtD
Ceftazidime—Gastrointestinal disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00202	0.0105	CcSEcCtD
Ceftazidime—Pain—Cyclosporine—focal segmental glomerulosclerosis	0.002	0.0104	CcSEcCtD
Ceftazidime—Gastrointestinal pain—Cyclosporine—focal segmental glomerulosclerosis	0.00191	0.00995	CcSEcCtD
Ceftazidime—Urticaria—Cyclosporine—focal segmental glomerulosclerosis	0.00186	0.00966	CcSEcCtD
Ceftazidime—Body temperature increased—Cyclosporine—focal segmental glomerulosclerosis	0.00185	0.00962	CcSEcCtD
Ceftazidime—Abdominal pain—Cyclosporine—focal segmental glomerulosclerosis	0.00185	0.00962	CcSEcCtD
Ceftazidime—Hypersensitivity—Cyclosporine—focal segmental glomerulosclerosis	0.00172	0.00896	CcSEcCtD
Ceftazidime—Pruritus—Cyclosporine—focal segmental glomerulosclerosis	0.00165	0.00861	CcSEcCtD
Ceftazidime—Diarrhoea—Cyclosporine—focal segmental glomerulosclerosis	0.0016	0.00832	CcSEcCtD
Ceftazidime—Dizziness—Cyclosporine—focal segmental glomerulosclerosis	0.00155	0.00805	CcSEcCtD
Ceftazidime—Vomiting—Cyclosporine—focal segmental glomerulosclerosis	0.00149	0.00774	CcSEcCtD
Ceftazidime—Rash—Cyclosporine—focal segmental glomerulosclerosis	0.00147	0.00767	CcSEcCtD
Ceftazidime—Dermatitis—Cyclosporine—focal segmental glomerulosclerosis	0.00147	0.00766	CcSEcCtD
Ceftazidime—Headache—Cyclosporine—focal segmental glomerulosclerosis	0.00146	0.00762	CcSEcCtD
Ceftazidime—Nausea—Cyclosporine—focal segmental glomerulosclerosis	0.00139	0.00723	CcSEcCtD
Ceftazidime—Ceftriaxone—ALB—focal segmental glomerulosclerosis	0.000243	0.374	CrCbGaD
Ceftazidime—Cefalotin—ALB—focal segmental glomerulosclerosis	0.000213	0.328	CrCbGaD
Ceftazidime—Cephalexin—ALB—focal segmental glomerulosclerosis	0.000194	0.298	CrCbGaD
